DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 8 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 64.1. According to RSI analysis, divislab is technically strong. 9.0 DIVISLAB RSI Chart
MACD (?) MACD: 21.3 and Signal Line: 20.1. According to MACD analysis, a bullish crossover just happend and it's a positive signal. But note that MACD is already positive. 8.0 DIVISLAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, divislab is in a strong uptrend. Major support levels are 1862.372, 1823.931, 1689.011. 10.0 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 20-day exponential moving average which is a positive signal. According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 1865.782, 1823.31, 1690.029. 9.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.947. According to bollinger bands, divislab is technically strong. 7.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1812.0292 and 1776.7. Resistance level is 1926.4. 6.5 DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 32.9 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 24.5 which means DIVISLAB is in a trading range and there is no trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 24, 2020
Open Price 1896.5
High Price 1914.7
Low Price 1885.1
Close Price 1910.5
Absolute Change 13.05
Percentage Change 0.688%
Weekly Change 0.376%
Monthly Change 4.39%
Yearly Change 25.5%
52-week high 1926.4
52-week low 1460.1
Corporate Actions
ExDate Purpose
August 14, 2019 AGM/DIV- RS 16 PER SH
August 31, 2018 AGM/DIV-RS 10 PER SHARE
September 15, 2017 AGM/DIV-RS 10/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.605
Confidence in Beta2.71%
Market Capital Rs. 50717.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 45.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 January 2020: Deliverable Quantity:4.26e+04 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 January 2020: Daily Volatility:0.193 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 January 2020: PCR_OI:0.451 PCR:0.325 NA DIVISLAB PCR Chart
Option Pain (?) 24 January 2020: Max Pain:1860.0 NA DIVISLAB Option Pain Chart
Premium (?) 24 January 2020 Premium: 1.3 Futures OI:2109200.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 24 January 2020: Price:1910.5 Put with maximum OI:1800.0 Call with maximum OI:1900.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 30, 2020 1911.8 2109200.0 1375.0 1375.0 1910.5
February 27, 2020 1919.5 88000.0 234.0 234.0 1910.5
March 26, 2020 1924.0 5200.0 5.0 5.0 1910.5

Announcements

April 09, 2018 DrDisc. under Reg.30 of SEBI (SAST) Reg.2011r. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
November 01, 2017 DiOutcome of Board Meetingivi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 21, 2020 February 05, 2020 Financial Results To consider and approve the financial results for the period ended December 31, 2019
October 25, 2019 November 05, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play